Literature DB >> 1407493

Perception of optical flow in cortical blindness: a case report.

D R Mestre1, M Brouchon, M Ceccaldi, M Poncet.   

Abstract

Motion perception was studied in a subject with bilateral lesion of the visual cortex, involving severe damage to cortical areas V1 and V4, but with no apparent damage to visual associative areas situated in occipito-parietal and lateral occipito-temporal (presumably V5) zones. He was able to perceive optical flow motions simulating motion in depth in "blind" parts of his visual field, provided that the stimulus-onset was temporally dissociated from its motion. Moreover, he was able to discriminate between different velocities and directions of motion. The results suggest that perimetrically "blind" parts of the visual field in this patient have true capacities to process visual motion. They are discussed in reference to the subject's ability to move freely in his environment and in reference to the role of extrastriate visual pathways in visual motion processing.

Entities:  

Mesh:

Year:  1992        PMID: 1407493     DOI: 10.1016/0028-3932(92)90082-w

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  4 in total

1.  "Real-time" obstacle avoidance in the absence of primary visual cortex.

Authors:  Christopher L Striemer; Craig S Chapman; Melvyn A Goodale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

2.  Visual field enlargement by neuropsychological training of a hemianopsia patient.

Authors:  G J van der Wildt; D P Bergsma
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

Review 3.  The autonomy of the visual systems and the modularity of conscious vision.

Authors:  S Zeki; A Bartels
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-11-29       Impact factor: 6.237

4.  Evidence that primary visual cortex is required for image, orientation, and motion discrimination by rats.

Authors:  Sarah K Petruno; Robert E Clark; Pamela Reinagel
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.